EQR
31
-13
FE
52
-10
BWA
21
-7
BIIB
30
-7
CME
46
-13
HBI
40
-5
EMC
1
-8
EIX
29
-14
ED
37
-12
IVZ
10
-9
DGX
36
-10
IP
40
-5
AIZ
52
-12
FLR
30
-10
AIV
30
-7
APH
48
-8
DOV
42
-7
ISRG
48
-11
F
42
-4
AMAT
20
-9
EQR
31
-13
FE
52
-10
BWA
21
-7
BIIB
30
-7
CME
46
-13
HBI
40
-5
EMC
1
-8
EIX
29
-14
ED
37
-12
IVZ
10
-9
DGX
36
-10
IP
40
-5
AIZ
52
-12
FLR
30
-10
AIV
30
-7
APH
48
-8
DOV
42
-7
ISRG
48
-11
F
42
-4
AMAT
20
-9
Financhill
Back

Invesco Biotechnology & Genome ETF Stock Predictions

Meet the founder that's revolutionizing smartphones

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
23

PBE
Invesco Biotechnology & Genome ETF

Last Price:
$58.94
Seasonality Move:
3.59%

7 Day Trial

ALL ACCESS PASS

$ 7

Crowdfunding to IPO: Nasdaq's Next Breakout?

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

Invesco Biotechnology & Genome ETF Stock Forecast

  • Over the next 52 weeks, Invesco Biotechnology & Genome ETF has on average historically risen by 9.9% based on the past 19 years of stock performance.
  • Invesco Biotechnology & Genome ETF has risen higher in 12 of those 19 years over the subsequent 52-week period, corresponding to a historical accuracy of 63.16%
  • Is Invesco Biotechnology & Genome ETF Stock Undervalued?
    The current Invesco Biotechnology & Genome ETF [PBE] share price is $59.05. The Score for PBE is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • PBE is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.

Will Invesco Biotechnology & Genome ETF Stock Go Up Next Year?

  • Over the next 52 weeks, Invesco Biotechnology & Genome ETF has on average historically risen by 9.9% based on the past 19 years of stock performance.

Invesco Biotechnology & Genome ETF Stock Rating

Sell
23
Invesco Biotechnology & Genome ETF (PBE) is a Sell

Is Invesco Biotechnology & Genome ETF overpriced?

  • Invesco Biotechnology & Genome ETF has risen higher in 12 of those 19 years over the subsequent 52-week period, corresponding to a historical accuracy of 63.16%

Invesco Biotechnology & Genome ETF Stock Price History

Is PBE stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PBE is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NYSEARCA
Country:
United States
Industry:
Sector:
Type:
etf
Website:

52-Week Data

52-Week High:
72.84
52-Week Low:
58.69

Prediction Charts

Market Cap:
0
Price in USD:
59.05
Volume:
11K
Beta:
0.94

Technical Analysis

SMA50:
66.63
SMA100:
67.73
SMA200:
68.20
52-Wk Change:
-5.62%

Stock Predictions

  • Is Invesco Biotechnology & Genome ETF stock public?
    Yes, Invesco Biotechnology & Genome ETF is a publicly traded company.
  • What is the Invesco Biotechnology & Genome ETF stock quote today?
    The Invesco Biotechnology & Genome ETF stock price is 59.05 USD today.
  • How to buy Invesco Biotechnology & Genome ETF stock online?
    You can buy Invesco Biotechnology & Genome ETF shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Mar-18 65.86 65.56 65.86 65.20
Mar-19 65.53 66.11 66.33 65.53
Mar-20 66.05 65.72 66.05 65.58
Mar-21 65.21 66.26 66.26 65.21
Mar-24 66.64 67.00 67.06 66.64
Mar-25 67.10 66.28 67.10 65.84
Mar-26 65.35 64.89 65.35 64.88
Mar-27 64.69 64.85 65.09 64.69
Mar-28 64.56 64.15 64.64 63.85
Mar-31 63.23 63.44 63.66 62.51
Apr-1 63.15 62.09 63.44 61.89
Apr-2 61.43 63.30 63.41 61.43
Apr-3 61.65 61.78 62.43 61.65
Apr-4 60.50 59.05 60.74 58.69

Invesco Biotechnology & Genome ETF Earnings

Data Unavailable

Invesco Biotechnology & Genome ETF Forecast Revenue Growth

Data Unavailable

* Invesco Biotechnology & Genome ETF stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.